edd/Vaccine

Lessons learnt during establishment of COVID-19 active vaccine safety surveillance in nine African countries.Cutland, C. L. Gutu, K. Yun, J. A. Izu, A. Mahtab, S. Peter, J. Ansah, N. A. Obaro, S. Tilahun, B. Jambo, K. Sow, S. Kagucia, E. W. Chicumbe, S. Dlamini, T. Browne, M. Clothier, H. Griffin, J. Jiang, Y. Lee, A. Ghebreab, L. Madhi, S. A. Black, S. B. Active vaccine safety surveillance, team
Vaccine, (2025). 62:127441

Seroprevalence of Immunoglobulin G against measles and rubella over a 12-year period (2009-2021) in Kilifi, Kenya and the impact of the Measles-Rubella (MR) vaccine campaign of 2016.Mburu, C. N. Ojal, J. Selim, R. Ombati, R. Akech, D. Karia, B. Tuju, J. Sigilai, A. Smits, G. van Gageldonk, P. G. M. van der Klis, F. R. M. Flasche, S. Kagucia, E. W. Scott, J. A. G. Adetifa, I. M. O.
Vaccine, (2025). 61:127425

Uptake and determinants of routine immunization among vulnerable children and adolescents in sub-Saharan Africa: A scoping review.Chege, C. K. Karanja, S. Ogallo, W. Were, F. van Hensbroek, M. B. Agweyu, A.
Vaccine, (2025). 54:127021

The impact of the COVID-19 pandemic on vaccine coverage in Kilifi, Kenya: A retrospective cohort study.Lucinde, R. K. Karia, B. Ouma, N. Amadi, D. Nyundo, C. Mataza, C. Nyaguara, A. Scott, J. A. G. Gallagher, K. E. Kagucia, E.
Vaccine, (2023). 41:666-675

WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use.Sparrow, E. Adetifa, I. Chaiyakunapruk, N. Cherian, T. Fell, D. B. Graham, B. S. Innis, B. Kaslow, D. C. Karron, R. A. Nair, H. Neuzil, K. M. Saha, S. Smith, P. G. Srikantiah, P. Were, F. Zar, H. J. Feikin, D.
Vaccine, (2022). 40:3506-3510

Unmet need for COVID-19 vaccination coverage in Kenya.Muchiri, S. K. Muthee, R. Kiarie, H. Sitienei, J. Agweyu, A. Atkinson, P. M. Edson Utazi, C. Tatem, A. J. Alegana, V. A.
Vaccine, (2022). 40:2011-2019

Coverage and timeliness of vaccination and the validity of routine estimates: Insights from a vaccine registry in Kenya.Adetifa, I. M. O. Karia, B. Mutuku, A. Bwanaali, T. Makumi, A. Wafula, J. Chome, M. Mwatsuma, P. Bauni, E. Hammitt, L. L. Mataza, C. Tabu, C. Kamau, T. Williams, T. N. Scott, J. A. G.
Vaccine, (2018). 36:7965-7974

Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data.Ojal, J. Flasche, S. Hammitt, L. L. Akech, D. Kiti, M. C. Kamau, T. Adetifa, I. Nurhonen, M. Scott, J. A. G. Auranen, K.
Vaccine, (2017). 35:4561-4568

Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.Verani, J. R. Baqui, A. H. Broome, C. V. Cherian, T. Cohen, C. Farrar, J. L. Feikin, D. R. Groome, M. J. Hajjeh, R. A. Johnson, H. L. Madhi, S. A. Mulholland, K. O'Brien, K. L. Parashar, U. D. Patel, M. M. Rodrigues, L. C. Santosham, M. Scott, J. A. Smith, P. G. Sommerfelt, H. Tate, J. E. Victor, J. C. Whitney, C. G. Zaidi, A. K. Zell, E. R.
Vaccine, (2017). 35:3295-3302

Case-control vaccine effectiveness studies: Data collection, analysis and reporting results.Verani, J. R. Baqui, A. H. Broome, C. V. Cherian, T. Cohen, C. Farrar, J. L. Feikin, D. R. Groome, M. J. Hajjeh, R. A. Johnson, H. L. Madhi, S. A. Mulholland, K. O'Brien, K. L. Parashar, U. D. Patel, M. M. Rodrigues, L. C. Santosham, M. Scott, J. A. Smith, P. G. Sommerfelt, H. Tate, J. E. Victor, J. C. Whitney, C. G. Zaidi, A. K. Zell, E. R.
Vaccine, (2017). 35:3303-3308

Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.Pan-Ngum, W. Kinyanjui, T. Kiti, M. Taylor, S. Toussaint, J. F. Saralamba, S. Van Effelterre, T. Nokes, D. J. White, L. J.
Vaccine, (2017). 35:403-409

Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya.Nyiro, J. U. Sande, C. Mutunga, M. Kiyuka, P. K. Munywoki, P. K. Scott, J. A. Nokes, D. J.
Vaccine, (2015). 33:1797-801

The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants.Sande, C. J. Cane, P. A. Nokes, D. J.
Vaccine, (2014). 32:4726-9

Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group.Satzke, C. Turner, P. Virolainen-Julkunen, A. Adrian, P. V. Antonio, M. Hare, K. M. Henao-Restrepo, A. M. Leach, A. J. Klugman, K. P. Porter, B. D. Sa-Leao, R. Scott, J. A. Nohynek, H. O'Brien, K. L. W. H. O. Pneumococcal Carriage Working Group
Vaccine, (2013). 32:165-79

Strategic priorities for respiratory syncytial virus (RSV) vaccine development.Anderson, L. J. Dormitzer, P. R. Nokes, D. J. Rappuoli, R. Roca, A. Graham, B. S.
Vaccine, (2013). 31 Suppl 2:B209-15

Spatial and socio-demographic predictors of time-to-immunization in a rural area in Kenya: Is equity attainable?.Moisi, J. C. Kabuka, J. Mitingi, D. Levine, O. S. Scott, J. A.
Vaccine, (2010). 28:5725-30

Mathematical model of the antibody response to hepatitis B vaccines: implications for reduced schedules.Wilson, J. N. Nokes, D. J. Medley, G. F. Shouval, D.
Vaccine, (2007). 25:3705-12

The preventable burden of pneumococcal disease in the developing world.Scott, J. A.
Vaccine, (2007). 25:2398-405

High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.Polley, S. D. Conway, D. J. Cavanagh, D. R. McBride, J. S. Lowe, B. S. Williams, T. N. Mwangi, T. W. Marsh, K.
Vaccine, (2006). 24:4233-46

Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.Polley, S. D. Mwangi, T. Kocken, C. H. Thomas, A. W. Dutta, S. Lanar, D. E. Remarque, E. Ross, A. Williams, T. N. Mwambingu, G. Lowe, B. Conway, D. J. Marsh, K.
Vaccine, (2004). 23:718-28